Home Newsfeeds ‘Tesla is ordered to upgrade self-driving computer for free over ‘false advertising” -Electrek

News

‘Tesla is ordered to upgrade self-driving computer for free over ‘false advertising” -Electrek

https://electrek.co/2022/12/12/tesla-ordered-upgrade-self-driving-computer-for-free-false-advertising/

byMichael Horton

December 12, 2022

1 minute read

Tesla ordered to upgrade self-driving computer for free due to ‘false advertising’

Russell 2000 Vs. S&P 500: Turning Tide For Small Caps? ‘Risk-Reward Trade-Off Is Very Skewed’

By Neil Dennis

March 27, 8:44 AM

Small cap stocks lag behind large cap tech stocks as investors chase high returns. This trend is worsened by rising interest rates, creating a big valuation gap.

AMD

News

Intapp Partners With BoardEx To Accelerate Business Development Efforts With Actionable Relationship Intelligence

By Happy Mohamed

May 24, 9:13 AM

Intapp (NASDAQ:INTA), a leading provider of cloud software for the global professional and financial services industry, today announced a new partnership with BoardEx, an Altrata company, to help private

INTA

Wells Fargo Initiates Coverage On CF Industries Holdings with Overweight Rating, Announces Price Target of $110

By Benzinga Newsdesk

January 19, 6:00 AM

Wells Fargo analyst Richard Garchitorena initiates coverage on CF Industries Holdings (NYSE:CF) with a Overweight rating and announces Price Target of $110.

EF Hutton Reiterates Buy on Innoviva, Maintains $22.5 Price Target

By Benzinga Newsdesk

March 3, 10:15 AM

EF Hutton analyst Constantine Davides reiterates Innoviva (NASDAQ:INVA) with a Buy and maintains $22.5 price target.

INVA

‘Tesla is ordered to upgrade self-driving computer for free over ‘false advertising” -Electrek

Related Posts

Russell 2000 Vs. S&P 500: Turning Tide For Small Caps? ‘Risk-Reward Trade-Off Is Very Skewed’

Intapp Partners With BoardEx To Accelerate Business Development Efforts With Actionable Relationship Intelligence

Wells Fargo Initiates Coverage On CF Industries Holdings with Overweight Rating, Announces Price Target of $110

EF Hutton Reiterates Buy on Innoviva, Maintains $22.5 Price Target